The exclusive distribution agreement, supported by Terumo’s strong commitment, will accelerate commercialization of its ProSense™ cryoablation system to treat breast cancer tumors in Japan and Singapore, pending regulatory approval. Read more
This website stores cookies on your computer, and employs other similar means to automatically collect data. These means are used to improve your website experience and to enable us to better administer the website and its content. Please read our Cookies Policy for additional information.